Navigation Links
Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Date:5/12/2008

CAMBRIDGE, Mass., May 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Tuesday, May 20, 2008 at 12:00 p.m. CEST at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceutical Contact:

Ron Renaud (617) 995-9800


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...
(Date:12/14/2009)... - Results From a Survey Conducted by ... Major Industrialized Countries , , - A ... impacts their enjoyment of the ... arthritis find shopping for gifts, ... difficult to do, ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... December 2009 -- Researchers have discovered a new explanation for ... more excess copies of a certain gene, the more serious ... and it is suspected that it is the amount of ... are being published in the American Journal of Human ... group of Guy Froyen connected to VIB, a life sciences ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Amount of gene surplus determines severity of mental retardation in males 2
... Enoch, S. Guenneau and A.B. Movchan , ... building stronger ocean-based structures to withstand tsunamis, it ... disappear. A collaboration of physicists from the Centre ... Universite in France and the University of Liverpool ...
... PharmAthene, Inc.,(Amex: PIP ), a biodefense company ... today that the National,Institute of Allergy and Infectious ... (NIH), has awarded the Company a multi-year contract,for ... a third generation,recombinant protective antigen (rPA) anthrax vaccine., ...
... and VERNON HILLS, Ill., Sept. 26 ,Winston Laboratories, ... of products for pain management, and Getting Ready ... GTRY), completed,a merger on September 25, 2008, pursuant ... Winston with and into Winston Acquisition Corp., a,wholly-owned ...
Other Biology Technology:Tsunami invisibility cloak, dark energy v. the void, sorting nanotubes with light, and more 2Tsunami invisibility cloak, dark energy v. the void, sorting nanotubes with light, and more 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 2PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 4PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 5PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 6Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 2Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 3Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 4
(Date:12/14/2009)... diseases can be transmitted by sneezing, touching, or ... face, a habit that may have driven the dinosaurs ... , Jacqueline Upcroft, a member of f1000 Biology, highlights ... published in PLoS One. This led them to deduce ... diseased jaw bones seen in many tyrannosaurid fossils. , ...
(Date:12/14/2009)... 2009If you are spending the holidays with big Uncle ... would be better off with another family, spare a ... research team from McMaster University and the University of ... species that lives in groups, members make strategic decisions ... in the current issue of Biology Letters . ...
(Date:12/14/2009)... Nations Framework Convention on Climate Change taking place ... ,Bend the Trend, event on Sunday evening to ... the screening of the new ,Environmental Atlas of ... joint project of the European Environment Agency (EEA), ... a series of short films showing the significance ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 1Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 2Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 3Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 4Anesthetix Launches OPTIMETRIX 28TM 29 Perioperative Quality Management Tool 55473 1Anesthetix Launches OPTIMETRIX 28TM 29 Perioperative Quality Management Tool 55473 2Anesthetix Launches OPTIMETRIX 28TM 29 Perioperative Quality Management Tool 55473 3
... Cellulose--a fibrous molecule found in all plants--is the ... also a favored target of renewable, plant-based biofuels ... about how plant cells synthesize individual cellulose fibers. ... Department of Plant Biology and Stanford University describes ...
... engineering at New Jersey Institute of Technology (NJIT) who is ... two grants that will help her bring the promise of ... , Arinzeh received a $700,000 grant from the New ... funds spinal cord research. She will use the grant to ...
... When medics are treating trauma patients, every second counts. ... it difficult to locate veins and administer lifesaving drugs ... Institute of Technology researchers is developing an inexpensive, handheld ... quickly. , "Depth and angle are the critical ...
Other Biology News:Formation of cellulose fibers tracked for the first time 2NJIT engineer poised to take stem cell research a step forward 2NJIT engineer poised to take stem cell research a step forward 3Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3
NPT1 (M-19)...
... These versatile vacuum cups provide ... smooth, curved, or irregular surfaces. ,PFG: ... Short Bellows cup ,PCG: Multiple Bellows ... typically from 25 to 200 mm ...
8 different frozen tissues are mounted on positively charged glass slides...
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
Biology Products: